Article Versions Notes

Blasco L, Ambroa A, Lopez M, Fernandez-Garcia L, Bleriot I, Trastoy R, Ramos-Vivas J, Coenye T, Fernandez-Cuenca F, Vila J, et al. Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii. Microorganisms. 2019; 7(11):556. https://doi.org/10.3390/microorganisms7110556

Blasco, Lucia, Anton Ambroa, Maria Lopez, Laura Fernandez-Garcia, Ines Bleriot, Rocio Trastoy, Jose Ramos-Vivas, Tom Coenye, Felipe Fernandez-Cuenca, Jordi Vila, and et al. 2019. "Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii" Microorganisms 7, no. 11: 556. https://doi.org/10.3390/microorganisms7110556

Blasco, L., Ambroa, A., Lopez, M., Fernandez-Garcia, L., Bleriot, I., Trastoy, R., Ramos-Vivas, J., Coenye, T., Fernandez-Cuenca, F., Vila, J., Martinez-Martinez, L., Rodriguez-Baño, J., Pascual, A., Cisneros, J. M., Pachon, J., Bou, G., & Tomas, M. (2019). Combined Use of the Ab105-2φΔCI Lytic Mutant Phage and Different Antibiotics in Clinical Isolates of Multi-Resistant Acinetobacter baumannii. Microorganisms, 7(11), 556. https://doi.org/10.3390/microorganisms7110556